Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orchids Paper Products CO /DETIS · Entity 158423 | Director | April 30, 2018 | May 02, 2018 |
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Director | May 20, 2025 | May 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orchids Paper Products CO /DE
Report date April 30, 2018 · Filed May 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.43 · Expires 2028-04-30 | Direct | 5,000 |
Reported balance
After 2018-04-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-30 · Grant · Disposed 5,000 · Balance 5,000 |
ROCKWELL MEDICAL, INC.
Report date May 20, 2025 · Filed May 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,831 |
Reported balance
After 2025-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-20 · Grant · Acquired 50,000 · Balance 148,831 F1: Restricted stock units vest on May 20, 2026. F2: This amount has been adjusted to correct an earlier filing. |
| Common StockSEC Table I · non-derivative | IndirectBy: Alyssa Danielle Ravich 1991 Irrevocable Trust | 1,454 |
Reported balance
Holding disclosure · report date 2025-05-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,454 F3: Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy: Alexander Coleman Ravich 1991 Irrevocable Trust | 818 |
Reported balance
Holding disclosure · report date 2025-05-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 818 F4: Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest on May 20, 2026.
F2: This amount has been adjusted to correct an earlier filing.
F3: Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust.
F4: Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2025 Filed May 21, 2025 19:06 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051712 · tm2515860-7_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,831 F1 · kind: Restricted stock units vest on May 20, 2026. F2 · balance_after: This amount has been adjusted to correct an earlier filing. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 16:21 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 19,991 | $2.32 | $46,379.12 |
DisclosureSEC source: 0001104659-24-120577 · tm2428911-1_4seq1.xml · nonDerivative · entry 2 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By: Revocable Trust of Mark H Ravich Disclosed balance after: 0 F1 · ownership.nature: Represents securities owned directly by Revocable Trust of Mark H Ravich ("MHR Trust"). Mr. Ravich, as the trustee of MHR Trust, may be deemed to beneficially own the securities owned directly by MHR Trust. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 16:21 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | SaleCommon Stock | 10,000 | $2.40 | $24,000.00 |
DisclosureSEC source: 0001104659-24-120577 · tm2428911-1_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,429 Read SEC document |
| May 21, 2024 Filed May 23, 2024 19:09 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 36,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-064814 · tm2415466-5_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,831 F1 · kind: Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| May 23, 2023 Filed May 25, 2023 16:14 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064632 · tm2316982-2_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,319 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069689 · tm2218111-4_4seq1.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,604 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:27 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012675 · wf-form4_162439722360264.xml · derivative · entry 5 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F5 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:27 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012675 · wf-form4_162439722360264.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,604 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:58 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 219,905 | $1.22 | $269,163.72 |
DisclosureSEC source: 0001628280-20-017292 · wf-form4_160755112113783.xml · nonDerivative · entry 2 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BY: Revocable Trust of Mark H Ravich Disclosed balance after: 219,905 F1 · kind: Represents the transfer of shares of common stock from Cindy Libman Irrevocable Trust ("CL Trust") to Revocable Trust of Mark H Ravich ("MHR Trust"). The Reporting Person is the trustee of each of the CL Trust and the MHR Trust. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfer reported herein. F3 · ownership.nature: Represents securities owned directly by Revocable Trust of Mark H Ravich ("MHR Trust"). Mr. Ravich, as the trustee of MHR Trust, may be deemed to beneficially own the securities owned directly by MHR Trust. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 16:58 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 219,905 | $1.22 | $269,163.72 |
DisclosureSEC source: 0001628280-20-017292 · wf-form4_160755112113783.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Cindy Libman Irrevocable Trust Disclosed balance after: 0 F1 · kind: Represents the transfer of shares of common stock from Cindy Libman Irrevocable Trust ("CL Trust") to Revocable Trust of Mark H Ravich ("MHR Trust"). The Reporting Person is the trustee of each of the CL Trust and the MHR Trust. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfer reported herein. F2 · ownership.nature: Represents securities owned directly by CL Trust. Mr. Ravich, as the trustee of CL Trust, may be deemed to beneficially own the securities owned directly by CL Trust. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 25,000 | $1.22 | $30,500.00 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 7 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Cindy Libman Irrevocable Trust Disclosed balance after: 219,905 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F10 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range. F7 · ownership.nature: Represents securities owned directly by CL Trust. Mr. Ravich, as the trustee of CL Trust, may be deemed to beneficially own the securities owned directly by CL Trust. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 9,000 | $1.16 | $10,440.00 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 6 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Alyssa Danielle Ravich 1991 Irrevocable Trust Disclosed balance after: 16,000 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F9 · ownership.nature: Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 16,000 | $1.16 | $18,560.00 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 5 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Alexander Coleman Ravich 1991 Irrevocable Trust Disclosed balance after: 9,000 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F8 · ownership.nature: Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 10,000 | $1.16 | $11,600.00 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 4 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,604 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F3 · balance_after: Includes 30,000 shares of common stock underlying unvested restricted stock units that vest based on the achievement of certain time-based milestones. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 194,905 | $1.22 | $237,784.10 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 3 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Cindy Libman Irrevocable Trust Disclosed balance after: 194,905 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.20 to $1.23 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range. F7 · ownership.nature: Represents securities owned directly by CL Trust. Mr. Ravich, as the trustee of CL Trust, may be deemed to beneficially own the securities owned directly by CL Trust. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 11,000 | $1.21 | $13,310.00 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 2 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Norman and Sally Ravich Family Trust Disclosed balance after: 0 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F4 · shares: Includes 1,000 shares which were inadvertently omitted in previous filings due to administrative error. F5 · ownership.nature: Represents securities owned directly by Norman and Sally Ravich Family Trust ("NSR Trust"). Mr. Ravich, as the trustee of NSR Trust, may be deemed to beneficially own the securities owned directly by NSR Trust. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 173,905 | $1.21 | $210,425.05 |
DisclosureSEC source: 0001628279-20-000218 · wf-form4_159960646138892.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,604 F1 · kind: Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range. F3 · balance_after: Includes 30,000 shares of common stock underlying unvested restricted stock units that vest based on the achievement of certain time-based milestones. Read SEC document |
| May 18, 2020 Filed May 20, 2020 16:40 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 34,024 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001628280-20-008127 · wf-form4_159000721396814.xml · derivative · entry 5 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,024 Underlying: Common Stock · 34,024 shares Expires 2030-05-18 F6 · derivative.exercise_date: Stock options vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 18, 2020 Filed May 20, 2020 16:40 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 30,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008127 · wf-form4_159000721396814.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,509 F1 · kind: Restricted stock units vest on May 18, 2021, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 19,759 shares of common stock underlying unvested restricted stock units that vest based on the achievement of certain time-based milestones. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 19:18 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 22,461 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001104659-19-034647 · a4.xml · derivative · entry 5 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,461 Underlying: Common Stock · 22,461 shares Expires 2029-06-06 Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 19:18 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 19,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-034647 · a4.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,709 F1 · kind: Restricted stock units vest on June 6, 2020. Read SEC document |
| December 21, 2018 Filed Dec 27, 2018 16:28 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 22,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-074918 · a4.xml · nonDerivative · entry 2 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,950 F2 · balance_after: Includes 22,200 shares of the Issuer's Common Stock distributed to Mr. Ravich in the transaction described in footnote (1). Read SEC document |
| December 21, 2018 Filed Dec 27, 2018 16:28 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 44,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-074918 · a4.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Norman J. Ravich Irrevocable Trust Disclosed balance after: 0 F1 · ownership.nature: Represents securities owned directly by Norman J. Ravich Irrevocable Trust ("NJR Trust"). On December 21, 2018, 44,400 shares of the Issuer's Common Stock held in this trust were distributed pro rata to the beneficiaries of the NJR Trust. 22,200 shares of the Issuer's Common Stock were distributed to Mr. Ravich and are reported in this Form 4 as directly owned. Mr. Ravich, as the trustee of NJR Trust, may be deemed to beneficially own the securities owned directly by NJR Trust. Read SEC document |
| April 30, 2018 Filed May 2, 2018 16:54 UTC | Orchids Paper Products CO /DE TIS · Entity 158423 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.43 | $0.00 |
DisclosureSEC source: 0001144204-18-024813 · tv492839_4.xml · derivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-04-30 Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 18:09 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 38,416 | $0.00 Strike: $5.75 | $0.00 |
DisclosureSEC source: 0001140361-18-014507 · doc1.xml · derivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,416 Underlying: Common Stock · 38,416 shares Expires 2028-03-19 F1 · security: The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the "2018 Plan") at the Company's 2018 Annual Meeting of Shareholders. If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person. F1 · kind: The grant of these options is contingent upon shareholder approval of the 2018 Rockwell Medical, Inc. Long Term Incentive Plan (the "2018 Plan") at the Company's 2018 Annual Meeting of Shareholders. If the Company's shareholders do not approve the 2018 Plan, these contingent options are deemed null and void and may not be exercised by the reporting person. Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:50 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCall Option (right to buy) · Derivative | 100 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001617 · form411265002_05232017.xml · derivative · entry 7 RAVICH MARK H · CIK 0000897727 · See Footnote 1 Norman J. Ravich Irrevocable Trust · CIK 0001698580 · See Footnote 1 Norman & Sally Ravich Family Trust · CIK 0001698591 · See Footnote 1 Alexander Coleman Ravich 1991 Irrevocable Trust · CIK 0001698545 · See Footnote 1 Alyssa Danielle Ravich 1991 Irrevocable Trust · CIK 0001698590 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Norman and Sally Ravich Family Trust Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-19 F6 · derivative.exercise_date: The Call Options reported herein were exercisable beginning on the date of their purchase. F1 · derivative.underlying: This Form 4 is filed jointly by Norman J. Ravich Irrevocable Trust ("NJR Trust"), Norman and Sally Ravich Family Trust ("NSR Trust"), Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"), Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust") and Mark H. Ravich (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The filing of this Form 4 shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer he or it does not directly own. F5 · ownership.nature: Represents securities owned directly by NSR Trust. Mr. Ravich, as the trustee of NSR Trust, may be deemed to beneficially own the securities owned directly by NSR Trust. Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:50 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCall Option (right to buy) · Derivative | 300 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001617 · form411265002_05232017.xml · derivative · entry 6 RAVICH MARK H · CIK 0000897727 · See Footnote 1 Norman J. Ravich Irrevocable Trust · CIK 0001698580 · See Footnote 1 Norman & Sally Ravich Family Trust · CIK 0001698591 · See Footnote 1 Alexander Coleman Ravich 1991 Irrevocable Trust · CIK 0001698545 · See Footnote 1 Alyssa Danielle Ravich 1991 Irrevocable Trust · CIK 0001698590 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2017-05-19 F6 · derivative.exercise_date: The Call Options reported herein were exercisable beginning on the date of their purchase. F1 · derivative.underlying: This Form 4 is filed jointly by Norman J. Ravich Irrevocable Trust ("NJR Trust"), Norman and Sally Ravich Family Trust ("NSR Trust"), Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"), Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust") and Mark H. Ravich (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The filing of this Form 4 shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer he or it does not directly own. Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:50 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 10,000 | $6.00 | $60,000.00 |
DisclosureSEC source: 0000921895-17-001617 · form411265002_05232017.xml · nonDerivative · entry 2 RAVICH MARK H · CIK 0000897727 · See Footnote 1 Norman J. Ravich Irrevocable Trust · CIK 0001698580 · See Footnote 1 Norman & Sally Ravich Family Trust · CIK 0001698591 · See Footnote 1 Alexander Coleman Ravich 1991 Irrevocable Trust · CIK 0001698545 · See Footnote 1 Alyssa Danielle Ravich 1991 Irrevocable Trust · CIK 0001698590 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Norman and Sally Ravich Family Trust Disclosed balance after: 10,000 F1 · security: This Form 4 is filed jointly by Norman J. Ravich Irrevocable Trust ("NJR Trust"), Norman and Sally Ravich Family Trust ("NSR Trust"), Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"), Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust") and Mark H. Ravich (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The filing of this Form 4 shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer he or it does not directly own. F5 · ownership.nature: Represents securities owned directly by NSR Trust. Mr. Ravich, as the trustee of NSR Trust, may be deemed to beneficially own the securities owned directly by NSR Trust. Read SEC document |
| May 19, 2017 Filed May 23, 2017 17:50 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | OtherCommon Stock | 30,000 | $6.00 | $180,000.00 |
DisclosureSEC source: 0000921895-17-001617 · form411265002_05232017.xml · nonDerivative · entry 1 RAVICH MARK H · CIK 0000897727 · See Footnote 1 Norman J. Ravich Irrevocable Trust · CIK 0001698580 · See Footnote 1 Norman & Sally Ravich Family Trust · CIK 0001698591 · See Footnote 1 Alexander Coleman Ravich 1991 Irrevocable Trust · CIK 0001698545 · See Footnote 1 Alyssa Danielle Ravich 1991 Irrevocable Trust · CIK 0001698590 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,750 F1 · security: This Form 4 is filed jointly by Norman J. Ravich Irrevocable Trust ("NJR Trust"), Norman and Sally Ravich Family Trust ("NSR Trust"), Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"), Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust") and Mark H. Ravich (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The filing of this Form 4 shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer he or it does not directly own. Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:25 UTC | Orchids Paper Products CO /DE TIS · Entity 158423 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001144204-17-024273 · v466025_4.xml · derivative · entry 1 RAVICH MARK H · CIK 0000897727 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-05-01 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.